Walleye Capital LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$83.14 - $145.99 $260,893 - $458,116	-3,138 Reduced 12.81%	21,354 $3.11 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $1.67 Million - $2.17 Million	15,195 Added 163.44%	24,492 $2.9 Million
Q4 2021 Mar 03, 2022	BUY	$99.73 - $148.48 $927,189 - $1.38 Million	9,297 New	9,297 $1.28 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $8,172 - $11,530	-200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $7,476 - $9,894	200 New	200 $8,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.